Search for: "Generic Pharmaceutical Association"
Results 121 - 140
of 3,015
Sorted by Relevance
|
Sort by Date
11 Dec 2013, 9:36 am
In July of this year, the pharmaceutical company settled nearly 7,000 claims for a total of $1.4 billion. [read post]
15 Oct 2009, 9:59 pm
" The paper was authored by Alfred Engelberg, a New York patent attorney who represented the Generic Pharmaceutical Industry Association and played a role in the passage of the Hatch-Waxman Act in 1984; Dr. [read post]
2 Oct 2013, 9:59 pm
By Donald Zuhn -- Last week, the Generic Pharmaceutical Association (GPhA) released a statement regarding a California bill (SB-598) that the GPhA asserted would "introduce[] burdensome provisions that could raise costs and limit patient access to more affordable biosimilar medicines." [read post]
24 Sep 2014, 3:25 pm
The Office of Inspector General (OIG) of the Department of Health & Human Services issued a Special Advisory Bulletin (SAB) on September 19, 2014 discussing the coupon programs employed by many pharmaceutical manufacturers to reduce or entirely eliminate patient copayments to obtain brand-name drugs. [read post]
23 Dec 2008, 8:57 pm
From the December 23 ETHEX press release we get some additional information from this generic drug company about its December 2008 recall of a single lot of Hydromorphone tablets: If someone were to take a higher than expected dose of Hydromorphone, the risk of adverse effects known to be associated with the drug may be increased, including respiratory depression (difficulty or lack of breathing), low blood pressure, and sedation. [read post]
1 Feb 2019, 1:01 pm
Health and Human Services Secretary Alex Azar and Inspector General Daniel Levinson proposed a rule on Thursday to eliminate safe harbor for companies engaging in kickbacks associated with prescription drug rebates. [read post]
9 Apr 2011, 7:59 am
Shah, Associate General Counsel - IP, Freddie MacAnna Linne, Attorney, IP Law, IBM Global Services- IP Law DivisionArian Duijvestijn, General Manager Lighting & Senior Vice President, Philips Intellectual Property & StandardsArti K. [read post]
18 Sep 2019, 6:35 am
” From the news release of the American Association for Justice. [read post]
22 Apr 2012, 9:30 pm
The vast majority of granted pharmaceutical patents are associated with drugs that are never approved, and more resources spent examining these patents would likely be wasted. [read post]
5 Sep 2012, 3:30 pm
Pioglitazone comes from Mylan Pharmaceuticals. [read post]
6 Apr 2009, 11:19 am
Global Pharmaceutical Association (GPhA), that represents the manufacturers and distributors of generic and active pharmaceuticals, says on its website: "As our nation acts to strengthen our health care system, our priority must be to reduce costs while increasing access to quality care. [read post]
1 Nov 2016, 6:10 am
Meanwhile, the patent term restoration provisions are likely to increase health care costs in Canada by delaying the availability of generic pharmaceuticals due to the extension in the term of protection for patented pharmaceuticals. [read post]
20 Jul 2014, 9:41 pm
July 20-22, 2014 - 2014 Annual Meeting & Conference (National Association of Patent Practitioners) - Alexandria, Virginia July 22, 2014 - "America Invents Act: Patent Strategies and Reforms Counsel Needs to Know" (Commercial Law WebAdvisor) - 1:00 to 2:30 pm (Eastern) July 23, 2014 - "Inter Partes Reviews of Pharmaceutical Patents: Understanding How IPRs are Changing the Landscape of Innovator/Generic Litigation" (Intellectual Property Owners… [read post]
5 Dec 2013, 3:17 pm
In this regard, this particular announcement touches on a number of more specific Bureau priorities, which include associations, regulated professions, pharmaceuticals and health care more generally (as well as the intersection of competition … read more » [read post]
15 Nov 2009, 8:16 pm
Yaz is manufactured and sold by Bayer Pharmaceuticals. [read post]
14 Jun 2017, 7:50 am
From the news release of the American Association for Justice. [read post]
7 Mar 2012, 7:23 pm
Educational programs and associated materials VA has defined an educational program as a pre-scheduled event or meeting with a pharmaceutical company representative in which information is provided about a drug or drug-related product. [read post]
6 Jan 2007, 11:52 am
Scott Hemphill, an Associate Professor of Law at Columbia, recently contacted me and let me know about their work. [read post]
7 Jul 2008, 10:59 am
At no time have any packages of Premarin or Premplus sold in Canada identified any association with U.S. [read post]
6 Apr 2024, 8:49 pm
This year's conference co-chairs include Andrei Iancu (Partner, Sullivan & Cromwell LLP and former Director of the USPTO), Brian Malkin (Associate General Counsel, Teva Pharmaceuticals), and Mira Mulvaney (Assistant General Patent Counsel, IP Litigation, Eli Lilly & Company). [read post]
